Form Type: 4

SEC EDGAR Link
Accession Number:0001385508-19-000077
Date:2019-08-01
Issuer: OPIANT PHARMACEUTICALS, INC. (OPNT)
Original Submission Date:

Reporting Person:

SKOLNICK PHIL
C/O OPIANT PHARMACEUTICALS, INC.
201 SANTA MONICA BLVD., SUITE 500 SANTA MONICA, CA 90401

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-08-01 M 10,000 a $9.00 10,000 direct
COMMON STOCK 2019-08-01 S 8,442 d $11.66 1,558 direct
COMMON STOCK 2019-08-02 S 1,558 d $11.30 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 9.0 2019-08-01 deemed execution date M 10,000 (d) 2018-08-06 2027-02-06 common stock 10,000 $9.00 90,000 direct
Footnotes
IDfootnote
f1 the option was exercised pursuant to a rule 10b5-1 trading plan entered into by the reporting person.
f2 the shares were sold pursuant to a rule 10b5-1 trading plan entered into by the reporting person.
f3 this transaction was executed in multiple trades at prices ranging from $11.00 to $12.30. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f4 this transaction was executed in multiple trades at prices ranging from $11.15 to $11.51. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
WhaleWisdom Logo

Elevate your investments